Elisabeth Niemoeller
-
- Diabetes Management and Research 41
- Diabetes Treatment and Management 39
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 3
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Pharmacology top 5%
- Pharmacology and Obesity Treatment 1
- Surgery top 5%
- Pancreatic function and diabetes 12
- Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer 18
- Genetics top 10%
- Diabetes and associated disorders 3
- Co-authors
- Julio RosenstockAkiyoshi TakamiRonnie AronsonYutaka SeinoElisabeth SouhamiKyung Wan MinHailing GuoM Hanefeld
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Elisabeth Niemoeller
41 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Endocrinology, Diabetes and Metabolism 1.8k
- Pharmacology 264
- Surgery 650
- Molecular Biology 752
- Genetics 204
Countries citing papers authored by Elisabeth Niemoeller
This map shows the geographic impact of Elisabeth Niemoeller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Niemoeller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Niemoeller more than expected).
Fields of papers citing papers by Elisabeth Niemoeller
This network shows the impact of papers produced by Elisabeth Niemoeller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Niemoeller. The network helps show where Elisabeth Niemoeller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisabeth Niemoeller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 6 | |
| 4 | Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetesbreakdown → | 2023 | 111 |
| 5 | 2022 | 18 | |
| 6 | 2021 | 82 | |
| 7 | 2019 | 62 | |
| 8 | 2019 | 20 | |
| 9 | 2018 | 16 | |
| 10 | 2017 | 13 | |
| 11 | 2016 | 195 | |
| 12 | 2016 | 199 | |
| 13 | 2016 | 3 | |
| 14 | 2015 | 14 | |
| 15 | 2015 | 11 | |
| 16 | 2014 | 25 | |
| 17 | 2014 | 63 | |
| 18 | 2014 | 36 | |
| 19 | 2013 | 122 | |
| 20 | 2013 | 123 |
About Elisabeth Niemoeller
Elisabeth Niemoeller is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, having authored 43 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diabetes Management and Research (41 papers), Diabetes Treatment and Management (39 papers), Metabolism, Diabetes, and Cancer (18 papers), Pancreatic function and diabetes (12 papers), Diabetes and associated disorders (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Pharmacology and Obesity Treatment (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Pharmacology (264 citations) and Surgery (650 citations). Elisabeth Niemoeller has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Julio Rosenstock, Akiyoshi Takami, Ronnie Aronson, Yutaka Seino, Elisabeth Souhami, Kyung Wan Min, Hailing Guo, M Hanefeld, P. Miossec and Vanita R. Aroda. Their work appears in journals such as New England Journal of Medicine, Circulation and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.